UnitedHealth Group Incorporated (NYSE:UNH) Holdings Decreased by Valtinson Bruner Financial Planning LLC

Valtinson Bruner Financial Planning LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,727 shares of the healthcare conglomerate’s stock after selling 107 shares during the quarter. Valtinson Bruner Financial Planning LLC’s holdings in UnitedHealth Group were worth $874,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at $25,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the third quarter valued at $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Up 1.5 %

Shares of UNH opened at $488.52 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $446.85 billion, a price-to-earnings ratio of 31.52, a P/E/G ratio of 1.37 and a beta of 0.62. The stock’s 50-day moving average price is $511.36 and its 200 day moving average price is $550.33.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The company’s revenue was up 6.8% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.72%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Truist Financial cut their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.